ClinicalTrials.gg
RecruitingNCT07319403Updated Oct 13, 2026

Comparison of the Effects of Hip and Ankle Focused Progressive Exercise Training on Lower Extremity Function in Athletes With Chronic Ankle Instability

An interventional study of Gluteus Medius and Gluteus Maximus in Ankle Sprains, sponsored by Hacettepe University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by Hacettepe University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Feb 2026; still recruiting 9 months later.
Updated Oct 13, 2026Now RecruitingSite recruiting status changed+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 38 studies in Ankle Injuries with a site in Turkey — 8 open to participants now, 11 under way, none of them phase 3. Ankle Injuries · Turkey.

Planned enrollment
17th of 26
36 · median 45
Started
2026
with 3 others
No phase
23 of 38
7 open now
Primary completion
2026-11
later than 7 of 10 live
Registered
35th of 38
by date
Lead sponsor
4 of 38
Hacettepe University

Among the 38 studies in Ankle Injuries with a site in Turkey, this one is the 17th largest by planned enrollment of the 26 interventional ones that give a count, is one of 4 that started in 2026, is one of 23 with no phase, reaches primary completion later than 7 of the 10 other live ones, and was the 35th registered.

Ankle Injuries

354 studies on the registry are indexed under Ankle Injuries; 77 are open to participants now.

Browse Ankle Injuries studies →

Open to participants now

8 of the 38 studies in Ankle Injuries with a site in Turkey are open now. Recruiting first, the newest first:

2 more — sign in →

All 8 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 47 Ankle Injuries studies recruiting now, 11 (23%) set no upper age limit and 33 (70%) stop at 75 or younger; 10 take children under 18; 8 take healthy volunteers.

This study: 18 Years to 40 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 38 studies in Ankle Injuries with a site in Turkey, or all of them as a file.
02

Study summary

Chronic ankle instability refers to a combination of persistent mechanical and functional instability symptoms following an ankle sprain. Along with these symptoms, decreased proprioception, reduced neuromuscular control, poor postural control, limited dorsiflexion range of motion, decreased ankle strength, and altered lower-extremity biomechanics during functional activities are also observed. In addition, individuals with chronic ankle instability have been shown to exhibit limitations in energy transfer across the lower extremity. These symptoms may hinder patients' physical activity levels and athletic performance and negatively affect their quality of life. Since the lower extremity functions as a unit, changes in adaptive strategies at the ankle can lead to kinematic alterations in proximal joints. Although the instability originates at the ankle, higher-level joints are also affected, and it has even been reported that in this population, lower-extremity stability is primarily achieved through the hip joint. While the effectiveness of hip-focused exercises has begun to be investigated in the literature, the superiority of different muscle groups has not yet been compared.

Read the detailed description

Chronic ankle instability is characterized by persistent mechanical and functional impairments that may develop following a lateral ankle sprain. Individuals with this condition commonly exhibit reduced proprioception, impaired neuromuscular control, limited dorsiflexion range of motion, and altered lower-extremity biomechanics, all of which may negatively affect daily activities and athletic performance. These deficits often lead to compensatory strategies at more proximal segments, and emerging evidence suggests that hip musculature plays a meaningful role in maintaining dynamic ankle stability. However, the specific contribution of individual hip muscle groups has not yet been clearly defined.

This study is designed to compare the effects of strengthening different hip muscle groups -the gluteus medius and gluteus maximus- on functional and neuromuscular outcomes in individuals with chronic ankle instability. Participants will be randomly assigned to one of three parallel groups: a gluteus medius strengthening group, a gluteus maximus strengthening group, or a control group performing standard balance exercises. Each intervention group will follow a structured and progressively loaded exercise program targeting the designated muscle group. All participants will complete supervised training sessions throughout the intervention period.

The study protocol includes a baseline assessment session, a multi-week intervention phase, and a post-intervention evaluation. Outcome measures will include functional performance tests, assessments of neuromuscular control, and metrics related to dynamic stability. These outcomes will be collected before and after the intervention to determine differences between groups.

The aim of this protocol is to determine whether targeted strengthening of specific hip muscle groups yields superior improvements in individuals with chronic ankle instability. The findings are expected to enhance understanding of the role of proximal musculature in lower-extremity stability and contribute to more precise and effective rehabilitation strategies for this population.

03

Conditions studied

  • Ankle Sprains

Browse trials for

Keywords

  • Ankle Injuries
  • Muscle Strength
  • Exercise Training
04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Professional athletes aged between 18 and 40 years

Participation in sports for at least 3 years

History of at least one lateral ankle sprain that occurred at least 12 months prior to enrollment

At least two episodes of perceived ankle "giving way" and/or at least two recurrent lateral ankle sprains within the past 6 months, and/or a subjective feeling of ankle instability on the injured side

Exclusion criteria

Exclusion Criteria:

History of lower extremity surgery

History of fracture involving the lower extremity

Any lower extremity injury within the past 3 months that limited physical activity for more than one day

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    Gluteus Maximus

    Participants with chronic ankle instability will participate in a 6-week hip-focused exercise program emphasizing gluteus maximus activation.

    Other: Gluteus Maximus

  • Experimental
    Gluteus Medius

    Participants with chronic ankle instability will participate in a 6-week hip-focused exercise program emphasizing gluteus medius activation.

    Other: Gluteus Medius

  • Active comparator
    Control

    Participants with chronic ankle instability will participate in a 6-week exercise program commonly used in the rehabilitation of ankle instability

    Other: Control

Interventions

  • OtherGluteus Medius

    Participants with chronic ankle instability will undergo a 6-week hip-focused strengthening exercise program specifically targeting the gluteus medius muscle. The intervention aims to improve hip muscle strength and lower extremity stability.

  • OtherGluteus Maximus

    Participants with chronic ankle instability will participate in a 6-week hip-focused strengthening exercise program targeting the gluteus maximus muscle. The program aims to enhance hip extension strength and overall lower extremity stability.

  • OtherControl

    Participants with chronic ankle instability will perform a 6-week standard strengthening exercise program commonly used in the rehabilitation of ankle instability, without specific emphasis on targeted hip muscle strengthening.

06

What researchers measure

Primary outcomes

  1. Cumberland Ankle Instability Tool (CAIT)

    The Cumberland Ankle Instability Tool (CAIT) is a self-reported questionnaire designed to assess the severity of chronic ankle instability. It consists of 9 items evaluating ankle stability during daily and sports-related activities. Scores range from 0 to 30, with lower scores indicating greater perceived ankle instability. An increase in the CAIT score reflects clinical improvement in ankle stability.

    Time frame: Baseline and after 6 weeks

Secondary outcomes

  1. Functional Ankle Instability Questionnaire

    Self-reported functional ankle instability will be evaluated using the Functional Ankle Instability Questionnaire. The questionnaire will be administered face-to-face by a trained physiotherapist to assess perceived ankle instability during daily and sports-related activities.

    Time frame: Baseline and after 6 weeks

  2. Hip Muscle Strength

    Isometric hip abduction and hip extension muscle strength will be assessed using a handheld dynamometer (KForce Muscle Controller, KInvent, USA). Hip abduction strength will be measured in a side-lying position at 25° of hip abduction with the knee extended, targeting the gluteus medius muscle. Hip extension strength will be measured in a prone position with the knee flexed at 90°, targeting the gluteus maximus muscle. Three trials will be performed bilaterally, and the mean value will be used for analysis.

    Time frame: Baseline and after 6 weeks

  3. Side Hop Test

    Functional performance will be assessed using the Side Hop Test. Participants will be instructed to perform repeated lateral hops on one leg over a single reference line as quickly as possible for 30 seconds. The total number of successful hops will be recorded. The test will be performed three times, and the highest value will be used for analysis.

    Time frame: Baseline and after 6 weeks

  4. Step-Down Test

    Postural stability and lower extremity kinematics will be evaluated using the Step-Down Test. Participants will stand on a raised platform on the test limb with hands placed on the waist and perform a controlled step-down by lowering the contralateral heel toward the ground and returning to the starting position. The movement will be performed at a standardized pace. The movement quality will be evaluated based on trunk, pelvis, and knee alignment.

    Time frame: Baseline and after 6 weeks

  5. Y-Balance Test

    Dynamic balance will be assessed using the Y-Balance Test. Participants will perform maximal reach distances in the anterior, posteromedial, and posterolateral directions while standing on the dominant limb. Reach distances will be normalized to limb length. The average of three trials in each direction will be used for analysis.

    Time frame: Baseline and after 6 weeks

  6. Single-Leg Heel Raise Balance Test

    Static balance will be assessed using the single-leg heel raise balance test. Participants will stand on one leg and perform plantar flexion while maintaining balance. The test will be terminated when the heel touches the ground. The average duration of three trials will be recorded.

    Time frame: Baseline and after 6 weeks

  7. Weight-Bearing Lunge Test

    Ankle dorsiflexion range of motion will be assessed using the weight-bearing lunge test. Participants will lunge forward toward a wall while maintaining heel contact with the ground. The maximum distance between the great toe and the wall will be measured. Three trials will be performed for each limb, and the mean value will be used for analysis.

    Time frame: Baseline and after 6 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Law on the Protection of Personal Data (LPPD)

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for Nov 2026, 9 months after the start.

Of 141 non-industry interventional studies with no phase under Ankle Injuries, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 31. This study's planned 9 months is close to that.

Counting every sponsor, half of 144 studies reached it within 9 months; a quarter within 4 and three quarters within 31.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 13, 2026: start Jan 2026 → Feb 2026, primary completion Apr 2026 → Nov 2026 and completion Aug 2026 → Nov 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 21, 2025
First posted
Jan 6, 2026
StartActual
Feb 15, 2026was Jan 2026
Primary completionEst.
Nov 2026was Apr 2026
CompletionEst.
Nov 2026was Aug 2026
Last update
Oct 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 13, 2026
Sites
Hacettepe University is now Recruiting
Oct 13, 2026
Start date
Jan 15, 2026→Feb 15, 2026 (actual)
Oct 13, 2026
Primary completion
Apr 2026→Nov 2026
Oct 13, 2026
Study completion
Aug 4, 2026→Nov 2026
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    Not yet recruiting→Recruiting
    Hacettepe University is now Recruiting
    Start date Jan 15, 2026→Feb 15, 2026 (now actual)
    Primary completion Apr 2026→Nov 2026
    Study completion Aug 4, 2026→Nov 2026

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07319403
Responsible party
Çiğdem Demir (Student, Hacettepe University) — Principal investigator
First posted
Jan 6, 2026
Start date
Feb 15, 2026
Primary completion
Nov 2026 (estimated)
Completion
Nov 2026 (estimated)
Last update
Oct 13, 2026

Study contacts

Çiğdem Demir
Contact
fztcigdemdemir@gmail.com
+905444674810
İrem Düzgün
principal investigator · Hacettepe University
Gülcan Harput
principal investigator · Ankara Medipol University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion